Cargando…

Long Non-Coding RNA HAND2-AS1 Acts as a Tumor Suppressor in High-Grade Serous Ovarian Carcinoma

Long non-coding RNAs (lncRNAs) are increasingly being identified as crucial regulators in pathologies like cancer. High-grade serous ovarian carcinoma (HGSC) is the most common subtype of ovarian cancer (OC), one of the most lethal gynecological malignancies. LncRNAs, especially in cancers such as H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gokulnath, Priyanka, de Cristofaro, Tiziana, Manipur, Ichcha, Di Palma, Tina, Soriano, Amata Amy, Guarracino, Mario Rosario, Zannini, Mariastella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312972/ https://www.ncbi.nlm.nih.gov/pubmed/32517089 http://dx.doi.org/10.3390/ijms21114059

Ejemplares similares

Long Non-Coding RNA MAGI2-AS3 is a New Player with a Tumor Suppressive Role in High Grade Serous Ovarian Carcinoma
por: Gokulnath, Priyanka, et al.
Publicado: (2019)

PAX8 expression in high-grade serous ovarian cancer positively regulates attachment to ECM via Integrin β3
por: Soriano, Amata Amy, et al.
Publicado: (2019)

Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma
por: de Cristofaro, Tiziana, et al.
Publicado: (2016)

TumorMet: A repository of tumor metabolic networks derived from context-specific Genome-Scale Metabolic Models
por: Granata, Ilaria, et al.
Publicado: (2022)

Publisher Correction: TumorMet: A repository of tumor metabolic networks derived from context-specific Genome-Scale Metabolic Models
por: Granata, Ilaria, et al.
Publicado: (2022)

Correction to: Clustering analysis of tumor metabolic networks
por: Manipur, Ichcha, et al.
Publicado: (2020)

Clustering analysis of tumor metabolic networks
por: Manipur, Ichcha, et al.
Publicado: (2020)

A role for PAX8 in the tumorigenic phenotype of ovarian cancer cells
por: Di Palma, Tina, et al.
Publicado: (2014)

Identification of Novel Pax8 Targets in FRTL-5 Thyroid Cells by Gene Silencing and Expression Microarray Analysis
por: Di Palma, Tina, et al.
Publicado: (2011)

PAX8 as a Potential Target for Ovarian Cancer: What We Know so Far
por: Di Palma, Tina, et al.
Publicado: (2022)

Neuropilin-2 Is a Newly Identified Target of PAX8 in Thyroid Cells
por: Lucci, Valeria, et al.
Publicado: (2015)

Pax8 modulates the expression of Wnt4 that is necessary for the maintenance of the epithelial phenotype of thyroid cells
por: Filippone, Maria Grazia, et al.
Publicado: (2014)

Comparative genomics reveals a functional thyroid-specific element in the far upstream region of the PAX8 gene
por: Nitsch, Roberto, et al.
Publicado: (2010)

The metabolic stress-activated checkpoint LKB1-MARK3 axis acts as a tumor suppressor in high-grade serous ovarian carcinoma
por: Machino, Hidenori, et al.
Publicado: (2022)

Early anteroposterior regionalisation of human neural crest is shaped by a pro-mesodermal factor
por: Gogolou, Antigoni, et al.
Publicado: (2022)

Overexpression of Chromosome 21 miRNAs May Affect Mitochondrial Function in the Hearts of Down Syndrome Fetuses
por: Izzo, Antonella, et al.
Publicado: (2017)

Crizotinib and PARP inhibitors act synergistically by triggering apoptosis in high-grade serous ovarian cancer
por: Sahin, Irem Durmaz, et al.
Publicado: (2019)

Concurrent Primary Peritoneal Low-Grade Serous Carcinoma and Endometrial High-Grade Serous Carcinoma
por: Lockyer, Megan G., et al.
Publicado: (2015)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

Bilateral Serous Psammocarcinoma of Ovary: Rare Variant Low Grade Serous Carcinoma
por: Jena, Saubhagya Kumar, et al.
Publicado: (2015)

Cathepsin L-induced galectin-1 may act as a proangiogenic factor in the metastasis of high-grade serous carcinoma
por: Pranjol, Md Zahidul I., et al.
Publicado: (2019)

The Continuum of Serous Tumors of Low Malignant Potential and Low-Grade Serous Carcinomas of the Ovary
por: Wong, Kwong-Kwok, et al.
Publicado: (2007)

Oncogenes in high grade serous adenocarcinoma of the ovary
por: Manasa, Pacharla, et al.
Publicado: (2020)

Decreased Levels of GSH Are Associated with Platinum Resistance in High-Grade Serous Ovarian Cancer
por: Criscuolo, Daniela, et al.
Publicado: (2022)

BNC2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress
por: Cesaratto, Laura, et al.
Publicado: (2016)

BNC2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress
por: Cesaratto, Laura, et al.
Publicado: (2016)

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas
por: Sadlecki, Pawel, et al.
Publicado: (2018)

Low-grade serous carcinoma with extensive osseous metaplasia arising from ovarian serous cystadenofibroma
por: Ribeiro e Ribeiro, Renan, et al.
Publicado: (2021)

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
por: Dey, Puja, et al.
Publicado: (2022)

CT features of low grade serous carcinoma of the ovary
por: Pannu, Harpreet K.
Publicado: (2015)

Targeting the Microenvironment in High Grade Serous Ovarian Cancer
por: Nwani, Nkechiyere G., et al.
Publicado: (2018)

The Tumor Microenvironment of High Grade Serous Ovarian Cancer
por: Stack, M. Sharon, et al.
Publicado: (2018)

Cell Origins of High-Grade Serous Ovarian Cancer
por: Kim, Jaeyeon, et al.
Publicado: (2018)

Proteome profiling of low grade serous ovarian cancer
por: zadeh fakhar, Haniyeh Bashi, et al.
Publicado: (2019)

High-grade serous ovarian cancer: the clone wars
por: Salomon-Perzyński, Aleksander, et al.
Publicado: (2017)

Educational Case: High-Grade Serous Carcinoma of the Ovary
por: Bunde, Sophia, et al.
Publicado: (2021)

Low-Grade Serous Carcinoma of the Ovary: The Current Status
por: Babaier, Abdulaziz, et al.
Publicado: (2022)

Molecular Management of High-Grade Serous Ovarian Carcinoma
por: Punzón-Jiménez, Paula, et al.
Publicado: (2022)

Clinical Value of lncRNA MEG3 in High-Grade Serous Ovarian Cancer
por: Buttarelli, Marianna, et al.
Publicado: (2020)

High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis
por: Hatano, Yuichiro, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4lk8074ptfbrhu0ro6q3hl1452